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Backround: Erectile dysfunction (ED) is the inability of male reproductive 
organs within sexual intercourse caused by neurogenic and hormonal disord-
ers. There are some causes of ED such as hypertension, stress, neurological 
disorders, stroke, diabetes, atherosclerosis, lifestyle, alcohol, smoking, and 
age-related hormonal decline can cause infertility. The natural treatment of 
sexual dysfunction through aphrodisiac activity of the plant is to increase 
sexual hormones, spermatogenesis activity and through PDE5 inhibitors such 
as sildenafil, verdenafil, and tadalafil which can inhibit the hydrolysis of 
second messenger cGMP of penis smooth muscle cells. Primer Design for 
amplification of several PDE5 gene nucleotide sequences obtained from 
NCBI gen banks and tested directly through explosions at NCBI and also us-
ing MEGA 6, primer 3 plus, and fast PCR software. The natural treatment of 
sexual dysfunction through aphrodisiac activity from plants to increase sexual 
hormone, spermatogenesis activity and inhibitor PDE5 such as sildenafil, 
vardenafil, and tadalafil can inhibit hydrolysis second messenger of cells 
cGMP smooth penis muscles. Method: Primer design stages for several se-
quences are data supply, multiple sequence alignment, sequence trimming, 
primer design (fastPCR input), in silico PCR analysis, and primer evaluation 
(Primer Test, OligoCalc and BLAST). Results: Primer of PDE5 that is choo-
sen is with reverse sequence 5-TGCATTGACCATGTCTCTCGTT-3, forward 
5-CGCCGATCTGGGCTGAACTA-3 able to amplify template DNA at tem-
perature 67.2˚C, 65.8˚C, 63.7˚C, however, the DNA band fragment looks not 
very clear, while it is more clearly seen at Tm temperature 61.2˚C, 59.1˚C, 
57.8˚C and 57˚C. Conclusion: PDE5 primers can be amplified well at 
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temperature 61.2˚C, 59.1˚C, 57.8˚C and 57˚C. PDE5 primer succeeded in 
amplifying DNA with a product length of 402 bp. 
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1. Introduction 
Phospodiesterase is a group of enzymes that break down substrates such as 
phosphodiaterases which bind pyrophosphates from nucleotides and nucleotide 
sugars [1]. PDE5 degrades cyclic AMP (cAMP) and cyclic GMP (cGMP) second 
messenger molecules [2]. PDE5 has important role in transferring signal trans-
duction because PDE5 regulates nucleotide signals [3]. PDE5 often becomes the 
target of drugs, because it has the ability to regulate small levels of nucleotides, 
tissue distribution, substrate specificity and parmocology [4]. PDE5 is mediated 
by cAMP and cGMP so it is used as a therapy to treat erectile dysfunction, 
asthma, heart failure, inflammation and depression [5]. PDE5 plays a role in 
cAMP and cGMP degradation. The role of PDE5 is related to adenylate silage 
(AC) and guanylate cyclase (GC) in regulation and the duration of the intracel-
lular signaling mechanism [6]. cGMP hydrolyzes PDE5 which is expressed in 
vascular smooth muscle.  
PDE5 is found in the penile tissue of the corpus cavernosum which functions 
to regulate erectile physiology so that it can be used as a therapy or treatment for 
sexual dysfunction [1]. Erectile dysfunction can be detected by examining PDE5 
gene expression [4]. The success of PDE5 examination depends on the primer 
being designed [7]. The results of previous studies show that not all primers can 
detect the presence of PDE5. Chen et al. (2017) carried the research on culture 
neurons with maturation interference effects using PDE5 primers with sequences 
forward: CCGATCTGGGCTGAACTAACAA, reverse:  
CAGACAAGGAACAGGGAATAGC, there is no increase in neurons in the 
effects of maturation interference [8]. Whereas PDE5 primers that succeeded in 
amplifying DNA were carried out by Ryu et al. (2018) with sequence forward: 
AACTATTACTGTCAACGACTTACAGTTT, reverse:  
GCTTGGTCTTGAATGAAGTCA, successfully demonstrated that udenafil sup- 
presses TLR4 mRNA expression in the hypothalamus [9]. Another study con-
ducted by Fiore et al. (2018) with sequence forward:  
GGAGGAGAATACTGGCAAGA, reverse: GATGCATGGTAAGACAGGAC; in 
type 2 diabetic mice administrated sildenafil for 12 weeks could increase adipo- 
genesis and improve adipose tissue [10]. The amplification of PDE5 gene 
depends not only on the primers determined, but it also depends on other 
factors such as dNTP, PCR templates, number of cycles, polymerase enzymes, 
and technical and non-technical effects [11].  
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Repair of erectile dysfunction is done by detecting the PDE5 gene [12], then 
giving treatment with chemical compounds that believe to act as PDE5 
inhibitors [13]. Erectile dysfunction is the inability to achieve or maintain penile 
erection sufficient to have sexual intercourse with a partner [14]. Erection of the 
penis is influenced by various factors such as neuroendocrine and vascular 
mechanisms acting on the penis tissue [15] consisting of a pair of corpus 
cavernous and corpus spongiosum [16], where in the middle runs the urethra 
[17]. The results of the Massachusets Male Aging Study (MMAS) survey, in men 
aged 40 - 70 years get 52% of respondents suffered from erectile dysfunction 
(ED) to a certain degree, where the total ED were suffered by 9.6%, mild by 
25.2% and minimal by 17.2%. In Indonesia who come to the clinic of impotence, 
the result estimated is not much different. 
Erectile dysfunction is the inability of the male reproductive organs to have 
sexual intercourse due to the absence of penis erection [18]. The male 
reproductive system consists of the hypothalamus, pituitary, and testis [19]. 
Until now there have been much controversy about the cause of penis inability 
to erect ment is better and quality of life can be improved [20]. Causes of erectile 
dysfunction such as hypertension, stress, neurological disorders, stroke, diabetes, 
atherosclerosis, lifestyle, alcohol, smoking, and age-related hormonal dysfunction 
can cause infertility [15] [21] [22]. 
The natural treatment of sexual dysfunction through aphrodisiac activity [23] 
of the plant is to increase sexual hormones and spermatogenesis activity and 
through PDE5 inhibitors such as sildenafil, verdenafil, and tadalafil which can 
inhibit the hydrolysis of second messenger cGMP released into the muscle cells 
smooth penis [24]. One of the newest and can be taken orally is sildenafil citrate. 
Originally sildenafil is meant to treat heart disease. Apparently people obtained 
side effects such as increased erection [23]. The erection process normally 
depends on the balance process between the contraction phase and the 
relaxation of the smooth muscle cells of the penis that is influenced by the 
production of cyclic guanosine monophosphate (cGMP) [13]. Cyclic guanosine 
monophosphate is not continuously present because it will subsequently be 
degraded by PDE5 [12]. 
Phospodiesterase type 5 is often a drug target, as it has the ability to regulate 
nucleotide cyclic levels, tissue distribution, substrate specificity and parmocology 
[4]. The PDE inhibitor reduces cGMP-phospodiesterase so as to keep the blood 
vessels in the penis filled and the erections persist, extending or enhancing the 
physiological process effects mediated by cAMP and cGMP [24]. Erection begins 
with sexual stimulation of the parasympathetic nerve releasing No. Nitric Oxide 
is released when there is sexual stimulation. Nitric Oxide diffuses to the smooth 
muscle cells of the corpus cavernosum and activates the guanilic cyclase (GC) 
enzyme then converts the GTP nucleic into cGMP [18]. Cyclic guanosine 
monophosphate causes smooth muscle cells around the penis to become a 
relaxation that leads to an increase in blood in the penis tissues [23]. Blood is 
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then trapped in the penis resulting in an erection. Erection stops because the 
enzyme PDE5 hydrolyzes cGMP. Phosphodiasterase type 5 enzymes are in the 
penis tissue [18]. Erection process due to sexual stimulation can be seen in 
Figure 1. 
Erections are controlled by the corpus cavernosum through No. Nitric oxide 
(NO) is synthesized by the amino acid arginine and it is the main neurotrans-
mitter responsible for muscle relaxation in the penis tissues [13]. Testosterone 
also plays a role in modulation of erectile function and is responsible for the 
regulation of nitrite oxide synthase (NOS) for cGMP formation [4]. Treatment 
of erectile dysfunction can be done through PDE5 inhibitors that found in plants 
or foods that contain aphrodisiac compounds. Aphrodisiacs are substances that 
can increase sexual arousal or libido [25]. Aphrodisiacs are categorized into 
three groups: 1) substances that increase libido such as sexual desire, sex drive, 
2) substances that increase sexual potency such as erectile effectiveness, 3) sub-
stances that increase sexual pleasure [22]. The effectiveness of aphrodisiac can 
improve the stimulation of sexual behavior of the hypothalamus, pituitary, go-
nad, and rapidly increasing erections. The role of PDE is related to adenylyl cyc-
lase (AC) and guanilic cyclase (GC) in the regulation and duration of the intra-
cellular signaling mechanism [22]. Phospodiasterase type 5 hydrolyzes cGMP 
expressed the smooth muscle of the penis corpora cavernosum and vascular 
smooth muscle cells that enable the work of PDE5 inhibitors to regulate erectile 
dysfunction [4] (Table 1). 
 
Table 1. TaqMan human phospodiasterase gene test. 
Group   Category Description   # Human Gene Symbols 
PDE1   CaM-dependent PDE   3  PDE1A-PDE1C 
PDE2   cGMP-stimulated PDE   1  PDE2A 
PDE3   cGMP-inhibited PDE   2  PDE3A, PDE3B 
PDE4   cAMP-specific PDE   4  PDE4A-PDE4D 
PDE5   cGMP-specific PDE   1  PDE5A 
PDE6   Photoreceptor PDE   6  PDE6A-C, PDE6D, PDE6G, PDE6H 
PDE7   cAMP-specific PDE   2  PDE7A, PDE7B 
PDE8   cAMP-specific PDE   2  PDE8A, PDE8B 
PDE9   cGMP-specific PDE   1  PDE9A 
PDE10   dual specificity PDE   1  PDE10A 
PDE11   dual specificity PDE   1  PDE11A 
ENPP   ectonucleotide PPase/PDE  7  ENPP1-7 
SMase   sphingomyelin PDE, neutral  2  SMPD2, SMPD3 
ASM   sphingomyelin PDE, acid-like  3  SMPD1, SMPDL3A, SMPDL3B 
GDPD  glycerophosphodiester PDE  6  GDPD1-5, MIR16 
CNP    2'3'-cyclic nucleotide 3' PDE  1  CNP 
Controls       5  18S, ACTB, B2M, GAPDH, PPIA 
TOTAL        48 
T. W. Watuguly et al. 
 
 
DOI: 10.4236/ojapps.2018.89030 402 Open Journal of Applied Sciences 
 
 
Figure 1. Sexual stimulation that causes erections [3]. 
2. Methods 
2.1. Collecting Primer PDE5 
This study used software to identify the PDE5 gene that used to amplify the 
DNA template in polymerase chain reaction (PCR). The primer design for 
amplification of several PDE5 gene nucleotide sequences from FastPCR and 
genbank software (http://www.ncbi.nlm.nih.gov/) was tested directly on NCBI 
and used MEGA 6, primer 3 plus, and fastPCR. the primer design results 
obtained from the software are then filtered according to criteria design stages 
for multiple sequences are data inventory, multiple sequence alignment, se-
quence trimming, primer design (Input fastPCR), PCR in silico analysis, and 
primer evaluation (Primer Test, OligoCalc and BLAST). For Single sequences, it 
started with Inventory data, primer design (Input fastPCR), PCR analysis in 
silico, primer evaluation (Primer Test, OligoCalc and BLAST). Primer evaluation 
consists of Primer Test: Displays the primer character, oligocalc; The primer sec-
ondary structure, blast; searches primers in the overall genome (primer specific 
evaluation). The primer types are as follows; Primer gene specific (forward and 
reverse primer), oligo dT (16 - 20 primers) PCR mRNA. Primer size 18 - 20 bp, 
Percentage GC contents 40% - 60%, Tm per primer 55 - 60 centigrade, differ-
ence of forward and reverse primer not more than 2 Celsius, 3' end each primer 
there is G or C (5 last base there is 2G, 2C or GC), there is no recurrent base, 
avoid primer-template mismatch at 3' end, and avoid secondary structures 
formed on primers such as hairpin, self-complementary, and primer dimer. 
Hairpin; 
Self-complementary, and primer-dimer; 
From the results of the primary analysis, each design has 10 primers that are 
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strong candidates to choose from, but in this study only three primers to 
strengthen the DNA template that will be tested. The chosen primary is: 
From the results of the primer analysis, each design has 10 primers that are 
strong candidates to be chosen, but in this, there were three primers to amplify 
template of DNA that would be tested. The selected primersare: 
1) Sequence forward: 5-CGCCGATCTGGGCTGAACTA-3 
reverse: 5-TGCATTGACCATGTCTCTCGTT-3; 
2) Sequence forward: 5-GCCGATCTGGGCTGAACTAAC-3 
reverse: 5-GCTCACGGTTCCCTCAGAAT-3; 
3) Sequence forward: 5-CTGGGCTGAACTAACAAGCTC-3 
reverse: 5-AGAAAGCTCACGGTTCCCTC-3. 
2.2. PCR Procedure 
The purpose of PCR is to make a number of copies of a gene that amplified. 30 - 
40 cycles of PCR reaction cycle that took place in the machine. The PCR stage 
included denaturation at 94˚C, anneling 54˚C for primer attachment, extension 
at 72˚C. PDE5 gene amplification uses RT-PCR. The forward primer initiated 
the DNA multiplication process while the reverse primer limits the DNA poly-
merization reaction according to the expected product. The template of DNA 
obtained from cDNA synthesis would be added to the micro PCR tube according 
to the GoTaq® Green master mix kit procedure for 25 μl of reaction volume. 
Primers completed the template through the anneling process, then the exten-
sion process occured from the end of the 5-phosphate to the 3-OH end. The 
primer synthesized DNA exactly the same as the DNA template and produced 
the product as expected. Primers that hybridize more than one target area indi-
cated the primer non-specific to the template. Primer used to produce cDNA for 
PCR assays, as a new origin of DNA synthesis, and as the origin of DNA se-
quencing. 
3. Results and Discussion 
3.1. Primer Design 
The primer design for the amplification of several nucleotide sequences of the 
PDE5 gene from FastPCR software and genbank (http://www.ncbi.nlm.nih.gov/) 
was tested directly by blast on NCBI or also using MEGA 6, primer 3 plus, and 
fastPCR. NCBI is a server that contains data base about information [26]. This 
data base continues to be updated in accordance with the latest discoveries con-
cerning DNA, proteins, RNA compounds and others. There are three data base 
bases in the world that always exchange information that is genbank owned 
United States, EMBL (the European Molecular Biology Laboratory), and DDBJ 
(DNA Data Bank of Japan) [27]. 
Primer is a single short piece of DNA (oligonucleotide), a commonly used 
primer length ranging from 18 to 20 bases. Primer is one of the essential ingre-
dients required in polymerase chain reaction (PCR). Primer serves to initiate 
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polymerase chain reaction (PCR). It also serves to limit the area to be amplified 
in the PCR reaction [7]. Without a primer, PCR reactions will not occur even if 
enzymes and other components are readily available [28]. Ideally the primer has 
the right nucleotide base sequence in pairs with the base sequence of the target 
DNA to be amplified, and not attached to other non-targeted parts (misprim-
ing). Besides, it also pays attention to the arrangement of nucleotides, such as % 
GC, and the difference between temperature mealting between primer forward 
and primer reverse which is not too far 2 C differences ideally [7] [28]. 
1) The Inventory data from GenBank 
The design of PDE5 primers was carried out using the wistar rat nucleotide 
sequence accessed at NCBI (www.ncbi.nlm.nih.gov) with access code NM_133584.1 
GI: 19424279 with nucleotide bases is 3397 bp linear mRNA. The search is done 
by entering the PDE5 keyword on the NCBI home page by genre search type or 
nucleotide. Thereafter it obtained two different sequences of PDE5 nucleotides 
from different animals and humans. The sequence in detail it can be seen in fasta 
and next the nucleotide sequence copied to the notepad with fasta format, then it 
can blast through pick primers, and get primer so it will appear a number of de-
sired primers. In addition it also can by using software mega 6.06 through mul-
tiple sequence alignment, the sequences that have been successfully loaded will 
be in alignment, then do trimming sequences which are not used as a template 
in the primer design. Trimming sequences are performed on upstream and 
downstream sequences of alignment results. Limited trimming until found. The 
alignment results are then stored in fasta format for use as the template design 
primer and PCR in silico. 
2) Selection of candidates or primer selection  
Primer that has been obtained then is selected to determine the primers to be 
used. In general, primer selection depends on the purpose of amplification. 
Primer selection is expected according to the criteria so that a primer can be de-
clared good. 
3) Analysis PCR in silico  
PCR in silico is done using FastPCR software. The sequences are performed 
by uploading PCR, then running, so the columns in PCR silico result can be seen 
in the primer attachment area in each sequence, the nucleotide sequence and the 
position of the attachment area, the percentage of the primer attachment, the 
melting temperature and the size of the amplicon. The primer attachment area 
can be seen in the red column of nucleotide sequences showing the primer for-
ward attachment region and the blue-colored nucleotide being the primer re-
verse attachment region. 
4) Checking the primer characters 
The Fast PCR software can check the primary character through the primary 
test column. Primary nucleotides are inputted in the provided column, then in 
the oligo analysis column it will display the primary character in full so that it is 
adjusted whether the primer meets the criteria or not. Checking primary 
characters can also be done with oligocalc, a tool to test the primary characters 
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provided on the page http://biotools.nubic.northwestern.edu.OligoCalc.html. 
3.2. Primer Design Results 
Primer PDE5 design results using FastPCR software obtained primer forward as 
much as 30 and primer reverses 31 for the first sequence inventory. PCR in silico 
analysis results obtained 10 primers (Table 2). 
In the second sequence obtained forward primer 23 and reverse primer 22. 
Primer design results of genbank software (http://www.ncbi.nlm.nih.gov/) 
(Table 3). 
From the results of the primary analysis, there were 10 primers who became 
strong candidates to be chosen. But in this study, it was filtered again into three 
primers used to amplify DNA templates. The selected primary consists of 1) 
sequence forward: CGCCGATCTGGGCTGAACTA reverse:  
TGCATTGACCATGTCTCTCGTT, 2) forward:  
GCCGATCTGGGCTGAACTAAC reverse: GCTCACGGTTCCCTCAGAAT, 3) 
forward: CTGGGCTGAACTAACAAGCTC reverse:  
AGAAAGCTCACGGTTCCCTC. 
Primer is a component of PCR that determines the accuracy of DNA se-
quences that want to be amplified. The nucleotide sequence (primer) will be the 
determinant on which part of the primer will attach (anneal) to the genome [27]. 
If the nucleotide sequence does not match the gene code we want, it is sure that 
the result of PCR product is not satisfactory. Therefore, before stepping on the 
amplification stage with PCR, the use of primer should be ascertained prior to its 
specificity. The trick is to make the primer design [26]. 
From the results of successful primer candidates, one is considered to have 
more criteria as a potential primer pair used on amplification using PCR. Primer 
selection with consideration compared to the other primer pair 1 which has a 
small Tm so that it can anticipate the primer synthesis process. The primer of 
the design will usually be different with from the synthesis and with a slight 
temperature difference it will allow a slight difference in the synthesis results. 
The two primer couples obtained had the same GC content of 55%. The PDE5 
primers above only 1 primer is good to use when compared to other primers 
(Table 4). 
3.3. PDE5 Assay 
There are 24 different superfamilies of PDE5 genes that clasify into 11 different 
groups. PDE degrade the molecular second messenger cyclic AMP (cAMP) and 
cyclic GMP (cGMP) [3]. PDE plays an important role in signal transduction 
because PDE regulates nucleotide signals. PDE often is the target of drugs, 
because they have ability to regulate nucleotide nucleotide levels, tissue 
distribution, substrate specificity and parmocology [29]. PDE5 inhibitors extend 
or enhance the effects of pyatologic processes mediated by cAMP and cGMP. It 
also used as therapy for erectile dysfunction, asthma, heart failure, inflammation 
and depression [3]. 
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Table 2. Primer design results. 
Primer ID   Sequence (5'-3')    Tm (˚C) Primer_Quality (%) PCR_Fragment_Size (bp) Topt (˚C) 
1F3_1_72-89  CTGGGCTGAACTAACAAGCTC 53.0  92 
1R2_1_316-333  AGAAAGCTCACGGTTCCCTC 50.2  89    263     601 
1F3_1_72-89  TTACCGACTTCAGCGGAT  53.0  92 
1R21_1_156-174  CACTGAGCCGTGTTAAAGC  55.3  87    104     58 
1F3_1_72-89  TTACCGACTTCAGCGGAT  53.0  92 
1R22_1_137-156  CTTTGTGGTAGGCTCCGTCT 57.0  87    86     57 
1F3_1_72-89  TTACCGACTTCAGCGGAT  53.0  92 
1R6_1_293-310  GTGCTCCATGGCAGTACA  55.3  87    240     59 
1F3_1_72-89  TTACCGACTTCAGCGGAT  53.0  92 
1R23_1_119-136  TCTTTCCATCGGCAAAGA  51.3  87    66     56 
1F3_1_72-89  GCCGATCTGGGCTGAACTAAC 53.0  92 
1R13_1_223-242  GCTCACGGTTCCCTCAGAAT 57.7  87    172     602 
1F3_1_72-89  TTACCGACTTCAGCGGAT  53.0  92 
1R7_1_284-303  ATGGCAGTACAGCCAAGGTC 57.8  87    233     58 
1F3_1_72-89  TTACCGACTTCAGCGGAT  53.0  92 
1R11_1_247-266  AATCATGGCTTAAAGCGGCA 55.3  87    196     58 
1F22_1_256-277  AAGCCATGATTTGGACCATCGT 56.9  90 
1R5_1_295-316  TTGATGGTGCTCCATGGCAGTA 58.3  88    62     61 
1F22_1_256-277  CGCCGATCTGGGCTGAACTA 56.9  90 
1R6_1_293-310  TGCATTGACCATGTCTCTCGTT 55.3  87    56     402 
 
Table 3. Primer design results. 
Primer ID   Sequence (5'-3')    Tm (˚C) Primer_Quality (%) PCR_Fragment_Size (bp) Topt (˚C) 
2F7_1_68-87  CTGGGCTGAACTAACAAGCTC 59.9  90 
2R5_1_262-280  AGAAAGCTCACGGTTCCCTC 57.3  97    214     601 
2F12_1_209-230  CTGTGATCTCTCCGCCATTACT 56.5  88 
2R5_1_262-280  AATTCGGCTGCCACGAGTT  57.3  97    73     61 
2F9_1_179-198  GGAGTTGTTTCTGGCAATGC 56.2  87 
2R5_1_262-280  AATTCGGCTGCCACGAGTT  57.3  97    103     61 
2F2_1_4-24   CGCCATGATTTGGACCATCGT 58.4  85 
2R5_1_262-280  AATTCGGCTGCCACGAGTT  57.3  97    278     63 
2F14_1_227-247  TACTAAGCCCTGGCCTATTCA 54.8  85 
2R5_1_262-280  AATTCGGCTGCCACGAGTT  57.3  97    55     59 
2F17_1_251-268  CGCCGATCTGGGCTGAACTA 52.6  92 
2R4_1_282-299  TGCATTGACCATGTCTCTCGTT 52.5  88    50     402 
2F17_1_251-268  ACGGATAGCAGAACTCGT  52.6  92 
2R2_1_330-347  GGGCCTCAGCGTCTATGA  57.0  86    98     57 
2F7_1_68-87  GCCGATCTGGGCTGAACTAAC 59.9  90 
2R7_1_248-268  GCTCACGGTTCCCTCAGAAT 55.6  88    202     602 
2F1_1_2-21   GGCGCCATGATTTGGACCAT 59.1  79 
2R5_1_262-280  AATTCGGCTGCCACGAGTT  57.3  97    280     63 
2F12_1_209-230  CTGTGATCTCTCCGCCATTACT 56.5  88 
2R4_1_282-299  GATCAGCGGCATGTTCTA  52.5  88    92     57 
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Table 4. Primers PDE5 that have been used. 
Name  Sequence       Use 
PDE-RT  AATTCAGAGGCAGAGAT    RT primer [18] 
PDE5A-s  TGATCACCGGGACTTTACCT   PDE5A1 specific [18] 
PDE5B-s  TGCTATGTTGCCCTTTGGAG   PDE5A2 specific [18] [30] 
rPDE5A3  AGCCTGGGTGTAGCAGCTT   Rat PDE5A3 specific [30] 
Reverse  ACCCTCATAGATGGGCACAG   primer (R) wistar control [29] [30] 
Forward  AGCCATGTACGTAGCCATCC  primer (F) wistar control [29] [30] 
 
PDE5 plays a role in cAMP and cGMP degradation. The role of PDE5 is 
related to adenylate silase (AC) and guanilic cyclase (GC) in the regulation and 
duration of the intracellular signaling mechanism [6]. cGMP hydrolyzes PDE5 
expressed to the smooth muscle of the penis corpus cavernosum and the smooth 
muscle cells of the pulmonary vessels that enable the work of PDE5 inhibitors to 
regulate erectile dysfunction [30]. The primar success of PDE5 in amplifying 
DNA templates can be seen in Figure 2. 
Primer PDE5 (A) with sequence reverse 5-TGCATTGACCATGTCTCTCGTT-3, 
forwad 5-CGCCGATCTGGGCTGAACTA-3 able to amplify template DNA at 
temperature 67.2˚C, 65.8˚C, 63.7˚C, however, the DNA band fragment looks not 
very clear, while it is more clearly seen at Tm temperature 61.2˚C, 59.1˚C, 
57.8˚C and 57˚C. Figure 3, PDE5 primer succeeded in amplifying DNA with a 
product length of 402 bp. Whereas primars (B) and (C) on electrophoresis 
results with various optimization temperatures show unclear amplification in 
bands that appear with sequences (B) forward: GCCGATCTGGGCTGAACTAAC 
reverse: GCTCACGGTTCCCTCAGAAT, and sequences (C) forward:  
CTGGGCTGAACTAACAAGCTC reverse: AGAAAGCTCACGGTTCCCTC. 
Electrophoresis results of primar A, at 68˚C did not succeed in amplifying the 
DNA template, while the temperature of 67.2˚C, 65.8˚C, 63.7˚C, was succeed in 
amplifying but the band that appeared was not very bright while the temperature 
of 61.2˚C, 59.1˚C, 57.8˚C, 57˚C bands was brighter. The brighter band indicates 
higher DNA concentration than the less bright band. Primar B was at 63.7˚C, 
61.2˚C, 59.1˚C, 57.8˚C, 57˚C bands that appeared not too bright, and primer C 
at 68˚C, and 67.2˚C did not occur DNA amplification, but at temperatures 
65.8˚C, 63.7˚C, 61.2˚C, 59.1˚C, 57.8˚C, and 57˚C it was managed to amplify but 
the band that appeared was not too bright. From the 3 primers of PDE5 tested, 
there was only one primer that considered to be better at amplifying DNA 
templates. This shows that primers selection was strongly to determine the 
success of the DNA template amplification process. 
4. Conclusion 
The success of PDE5 gene amplification is highly dependent on the primer, the 
results of the primer design selected 3 primers that met the criteria, but there 
was only 1 primer to electrophoresis results was able to amplify the DNA  
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Figure 2. Hairpin and self-complementary and Primer-dimer. 
 
 
Figure 3. Electrophoresis of Primers PDE5. 
 
template in accordance with the desired results. In addition to the primary fac-
tors there are also other factors such as dNTP, PCR templates, number of cycles, 
polymerase enzymes, and technical and non-technical effects. But primer selec-
tion is one way to minimize failure of template DNA amplification. Primers that 
successfully amplify DNA template is sequence reverse:  
TGCATTGACCATGTCTCTCGTT, forward: CGCCGATCTGGGCTGAACTA. 
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